Approval · Notice of Compliance 951 · 2000
KOGENATE FS: Notice of Compliance 951
Issued July 24, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 951
- Date
- July 24, 2000
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Coagulation factor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KOGENATE FS | 02242489 | Cancelled Post Market |
| KOGENATE FS | 02242490 | Cancelled Post Market |
| KOGENATE FS | 02242491 | Cancelled Post Market |
Medicinal ingredients
- ANTIHEMOPHILIC FACTOR (RECOMBINANT) 250 UNIT per VIAL
- ANTIHEMOPHILIC FACTOR (RECOMBINANT) 500 UNIT per VIAL
- ANTIHEMOPHILIC FACTOR (RECOMBINANT) 1,000 UNIT per VIAL